Cargando…

Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing

Background: Cell therapy holds great promise for cutaneous wound treatment but presents practical and clinical challenges, mainly related to the lack of a supportive and inductive microenvironment for cells after transplantation. Main: This review delineates the challenges and opportunities in cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Motaharesadat, Dalley, Andrew J., Shafiee, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785239/
https://www.ncbi.nlm.nih.gov/pubmed/36559242
http://dx.doi.org/10.3390/pharmaceutics14122749
_version_ 1784858000681336832
author Hosseini, Motaharesadat
Dalley, Andrew J.
Shafiee, Abbas
author_facet Hosseini, Motaharesadat
Dalley, Andrew J.
Shafiee, Abbas
author_sort Hosseini, Motaharesadat
collection PubMed
description Background: Cell therapy holds great promise for cutaneous wound treatment but presents practical and clinical challenges, mainly related to the lack of a supportive and inductive microenvironment for cells after transplantation. Main: This review delineates the challenges and opportunities in cell therapies for acute and chronic wounds and highlights the contribution of biofabricated matrices to skin reconstruction. The complexity of the wound healing process necessitates the development of matrices with properties comparable to the extracellular matrix in the skin for their structure and composition. Over recent years, emerging biofabrication technologies have shown a capacity for creating complex matrices. In cell therapy, multifunctional material-based matrices have benefits in enhancing cell retention and survival, reducing healing time, and preventing infection and cell transplant rejection. Additionally, they can improve the efficacy of cell therapy, owing to their potential to modulate cell behaviors and regulate spatiotemporal patterns of wound healing. Conclusion: The ongoing development of biofabrication technologies promises to deliver material-based matrices that are rich in supportive, phenotype patterning cell niches and are robust enough to provide physical protection for the cells during implantation.
format Online
Article
Text
id pubmed-9785239
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97852392022-12-24 Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing Hosseini, Motaharesadat Dalley, Andrew J. Shafiee, Abbas Pharmaceutics Review Background: Cell therapy holds great promise for cutaneous wound treatment but presents practical and clinical challenges, mainly related to the lack of a supportive and inductive microenvironment for cells after transplantation. Main: This review delineates the challenges and opportunities in cell therapies for acute and chronic wounds and highlights the contribution of biofabricated matrices to skin reconstruction. The complexity of the wound healing process necessitates the development of matrices with properties comparable to the extracellular matrix in the skin for their structure and composition. Over recent years, emerging biofabrication technologies have shown a capacity for creating complex matrices. In cell therapy, multifunctional material-based matrices have benefits in enhancing cell retention and survival, reducing healing time, and preventing infection and cell transplant rejection. Additionally, they can improve the efficacy of cell therapy, owing to their potential to modulate cell behaviors and regulate spatiotemporal patterns of wound healing. Conclusion: The ongoing development of biofabrication technologies promises to deliver material-based matrices that are rich in supportive, phenotype patterning cell niches and are robust enough to provide physical protection for the cells during implantation. MDPI 2022-12-08 /pmc/articles/PMC9785239/ /pubmed/36559242 http://dx.doi.org/10.3390/pharmaceutics14122749 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hosseini, Motaharesadat
Dalley, Andrew J.
Shafiee, Abbas
Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing
title Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing
title_full Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing
title_fullStr Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing
title_full_unstemmed Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing
title_short Convergence of Biofabrication Technologies and Cell Therapies for Wound Healing
title_sort convergence of biofabrication technologies and cell therapies for wound healing
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785239/
https://www.ncbi.nlm.nih.gov/pubmed/36559242
http://dx.doi.org/10.3390/pharmaceutics14122749
work_keys_str_mv AT hosseinimotaharesadat convergenceofbiofabricationtechnologiesandcelltherapiesforwoundhealing
AT dalleyandrewj convergenceofbiofabricationtechnologiesandcelltherapiesforwoundhealing
AT shafieeabbas convergenceofbiofabricationtechnologiesandcelltherapiesforwoundhealing